Lundqvist Thomas, Stenlid Rasmus, Halldin Maria
Department of Women's and Children's Health, Karolinska Institutet, 171 76 Stockholm, Sweden.
Unit for Pediatric Endocrinology and Metabolic Disorders, Karolinska University Hospital, 171 76 Stockholm, Sweden.
Metabolites. 2025 Mar 28;15(4):235. doi: 10.3390/metabo15040235.
: Inborn errors of metabolism (IEMs) represent a diverse group of genetic disorders characterized by enzymatic defects that disrupt metabolic pathways, leading to toxic metabolite accumulation, deficits, or impaired macromolecule synthesis. While strict dietary interventions are critical for managing many of these conditions, hormonal and metabolic changes during puberty introduce new challenges. Advancements in early diagnosis and treatment have significantly extended the lifespan of individuals with IEMs. However, this increased longevity is associated with heightened risks of new medical problems, including obesity, insulin resistance, and type 2 diabetes mellitus (T2DM), as these complications share mechanistic features with those seen in obesity and T2DM. : This mini-review examines current knowledge of the intricate interplay between pubertal hormones and metabolic pathways in IEM patients. : We address critical questions, such as if puberty intensifies the risk of metabolic derangements in these individuals and if there is a metabolic intersection where these disorders converge, leading to shared complications. We highlight the impact of puberty-induced hormonal fluctuations, such as growth hormone (GH) surges and sex steroid activity, on disorders like phenylketonuria, urea cycle defects, and fatty acid oxidation disorders. Moreover, we explore the role of dietary interventions in mitigating or exacerbating these effects, emphasizing the importance of balancing nutritional needs during growth spurts. : A multidisciplinary approach integrating endocrinology, nutrition, and emerging therapies is advocated to optimize metabolic health during puberty. Addressing these challenges is critical for improving long-term outcomes for individuals with IEMs, particularly during this pivotal developmental phase.
先天性代谢缺陷(IEMs)是一组多样的遗传性疾病,其特征是酶缺陷扰乱代谢途径,导致有毒代谢物积累、缺乏或大分子合成受损。虽然严格的饮食干预对于控制其中许多病症至关重要,但青春期的激素和代谢变化带来了新的挑战。早期诊断和治疗的进展显著延长了IEM患者的寿命。然而,这种寿命的延长与新的医疗问题风险增加有关,包括肥胖、胰岛素抵抗和2型糖尿病(T2DM),因为这些并发症与肥胖和T2DM中的并发症具有共同的机制特征。 本综述探讨了IEM患者青春期激素与代谢途径之间复杂相互作用的现有知识。 我们提出了一些关键问题,例如青春期是否会增加这些个体代谢紊乱的风险,以及是否存在一个代谢交叉点,这些疾病在该点汇聚,导致共同的并发症。我们强调青春期引起的激素波动,如生长激素(GH)激增和性类固醇活性,对苯丙酮尿症、尿素循环缺陷和脂肪酸氧化障碍等疾病的影响。此外,我们探讨了饮食干预在减轻或加剧这些影响方面的作用,强调在生长突增期间平衡营养需求的重要性。 提倡采用内分泌学、营养学和新兴疗法相结合的多学科方法,以优化青春期的代谢健康。应对这些挑战对于改善IEM患者的长期预后至关重要,尤其是在这个关键的发育阶段。